Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Renalytix Plc (RENX.LN)

Renalytix Plc (RENX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 33,448
  • Shares Outstanding, K 119,916
  • Annual Sales, $ 3,403 K
  • Annual Income, $ -45,607 K
  • 60-Month Beta N/A
  • Price/Sales 12.69
  • Price/Cash Flow N/A
  • Price/Book 15.62
Trade RENX.LN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.45
  • Most Recent Earnings $-0.09 on 02/15/24
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.000 unch
on 04/25/24
36.000 -30.56%
on 03/26/24
-10.500 (-29.58%)
since 03/25/24
3-Month
10.000 +150.00%
on 02/08/24
74.900 -66.62%
on 02/13/24
+13.250 (+112.77%)
since 01/25/24
52-Week
10.000 +150.00%
on 02/08/24
150.000 -83.33%
on 07/13/23
-67.500 (-72.97%)
since 04/25/23
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.

Most Recent Stories

More News
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physicians Globe Newswire - Mon Aug 8, 2022

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022 Globe Newswire - Thu Jun 30, 2022

LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30 Globe Newswire - Thu Jun 23, 2022

NEW YORK and SALT LAKE CITY, June 23, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will report its third...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Globe Newswire - Fri Jun 10, 2022

Late-breaking data presented at American Diabetes Association Scientific Sessions® demonstrates increased adherence to care guidelines for physicians using...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort Globe Newswire - Mon Jun 6, 2022

Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes Association 82nd Scientific Sessions® Globe Newswire - Thu Jun 2, 2022

Real-world clinical utility in 1,112 patients tested with KidneyIntelX KidneyIntelX stratification for cardiovascular risk in 1,278 diabetic kidney...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
Renalytix plc successful completion of $30.0 million financing package Globe Newswire - Fri Apr 8, 2022

Director/PDMR Dealing...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
Renalytix plc Issue of shares Globe Newswire - Fri Apr 8, 2022

NEW YORK and SALT LAKE CITY, April 08, 2022 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) announces that under the Company's Employee...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
Renalytix announces a $30.0 million financing package Globe Newswire - Thu Mar 31, 2022

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022 Globe Newswire - Thu Mar 31, 2022

LONDON and SALT LAKE CITY, March 31, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro...

RNLX : 0.6331 (-0.42%)
RENX.LN : 25.500 (-3.77%)
More news for this symbol

Barchart Technical Opinion

sell

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 28.667
2nd Resistance Point 28.033
1st Resistance Point 27.267
Last Price 25.500
1st Support Level 25.867
2nd Support Level 25.233
3rd Support Level 24.467

See More

52-Week High 150.000
Fibonacci 61.8% 96.520
Fibonacci 50% 80.000
Fibonacci 38.2% 63.480
Last Price 25.500
52-Week Low 10.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot